Atlas Trials

A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Clinical trial NCT06158490 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06158490
Sponsor
Guangzhou JOYO Pharma Co., Ltd
Status
ENROLLING_BY_INVITATION
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate-to-severe Atopic Dermatitis
Start date
2023-12-27
Primary completion
2026-02-10
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.